Published in the Journal of Clinical Oncology, results showed no difference in any outcomes, including overall survival, at two years…
RIYADH, Saudi Arabia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has…
Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2nd generation antisense oligonucleotide (ASO), in…